- Home
- ZVIA vs DERM Comparison
ZVIA vs DERM Comparison
Compare ZVIA & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- DERM
- Stock Information
- Founded
- ZVIA 2007
- DERM 2014
- Country
- ZVIA United States
- DERM United States
- Employees
- ZVIA N/A
- DERM N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- DERM Health Care
- Exchange
- ZVIA Nasdaq
- DERM Nasdaq
- Market Cap
- ZVIA 193.4M
- DERM 213.6M
- IPO Year
- ZVIA 2021
- DERM 2021
- Fundamental
- Price
- ZVIA $2.69
- DERM $7.85
- Analyst Decision
- ZVIA Buy
- DERM Strong Buy
- Analyst Count
- ZVIA 5
- DERM 3
- Target Price
- ZVIA $4.89
- DERM $12.67
- AVG Volume (30 Days)
- ZVIA 787.3K
- DERM 236.1K
- Earning Date
- ZVIA 11-05-2025
- DERM 11-12-2025
- Dividend Yield
- ZVIA N/A
- DERM N/A
- EPS Growth
- ZVIA N/A
- DERM N/A
- EPS
- ZVIA N/A
- DERM N/A
- Revenue
- ZVIA $162,849,000.00
- DERM $59,399,000.00
- Revenue This Year
- ZVIA $6.44
- DERM $26.16
- Revenue Next Year
- ZVIA $6.68
- DERM $45.27
- P/E Ratio
- ZVIA N/A
- DERM N/A
- Revenue Growth
- ZVIA 6.17
- DERM 2.82
- 52 Week Low
- ZVIA $1.88
- DERM $3.54
- 52 Week High
- ZVIA $4.99
- DERM $9.40
- Technical
- Relative Strength Index (RSI)
- ZVIA 59.59
- DERM 48.08
- Support Level
- ZVIA $2.62
- DERM $7.42
- Resistance Level
- ZVIA $2.78
- DERM $8.18
- Average True Range (ATR)
- ZVIA 0.13
- DERM 0.49
- MACD
- ZVIA 0.01
- DERM -0.11
- Stochastic Oscillator
- ZVIA 69.12
- DERM 27.00
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.